Pro Share Advisors LLC Annexon, Inc. Transaction History

Pro Share Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$4.03 - $7.81 $48,771 - $94,516	12,102 New	12,102 $86,000
Q1 2022 May 10, 2022	SELL	$2.73 - $11.94 $33,352 - $145,870	-12,217 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$11.49 - $22.0 $390 - $748	34 Added 0.28%	12,217 $139,000
Q3 2021 Nov 12, 2021	SELL	$16.35 - $23.4 $45,453 - $65,051	-2,780 Reduced 18.58%	12,183 $227,000
Q2 2021 Aug 13, 2021	BUY	$17.81 - $27.48 $43,812 - $67,600	2,460 Added 19.68%	14,963 $337,000
Q1 2021 May 14, 2021	BUY	$22.0 - $35.01 $69,498 - $110,596	3,159 Added 33.81%	12,503 $348,000
Q4 2020 Feb 09, 2021	BUY	$20.81 - $30.55 $194,448 - $285,459	9,344 New	9,344 $234,000

156

101M

3.73M

1.3M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $300M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.